US 2012/0059004 A1Published application

Compounds And Compositions For Treating Cancer

AssigneeCanthera Therapeutics, Inc.

InventorsPETER ELLIOTT, ANNA MANDINOVA, MICHAEL ANDREW FOLEY, ROBERT GOULD, SAM LEE

Life of this patent

Estimating the term…

Abstract

The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed.

Claims15

Dependent claims

(canceled)

Dependencies are inferred from the claim text.

Facts

Application: 13/028,571Filed 16 Feb 2011
Priority: 2 Sep 2010
Published: 8 Mar 2012
Term ends: Not estimatedThe source records don’t support an estimate.

Classification11 codes

C07D 295/155
Substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals: with the ring…
A61K 31/4412
Non condensed pyridines; Hydrogenated derivatives thereof: having oxo groups directly attached to the heterocyclic ring
A61K 31/5377
1,4-Oxazines, e.g. morpholine: not condensed and containing further heterocyclic rings, e.g. timolol
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…

Family

Application12/874,306Continuation in part · filed 2 Sep 2010
Application13/028,571Continuation in part
US 2011/0053938 A1Published application
US 8,318,737 B2Related patent
US 8,349,832 B2Related patent
US 2012/0059004 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results